Product
Carboplatin + Liposomal Doxorubicin
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the PlatinumStatus: Completed, Estimated PCD: 2014-10-01